Pure Global

Urinary Retention Following taTME VS laTME Total Mesorectal Excision for Rectal Cancer - Trial NCT06147492

Access comprehensive clinical trial information for NCT06147492 through Pure Global AI's free database. This phase not specified trial is sponsored by Yanhong Deng and is currently Completed. The study focuses on Rectal Cancer. Target enrollment is 526 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06147492
Completed
procedure
Trial Details
ClinicalTrials.gov • NCT06147492
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Urinary Retention Following taTME VS laTME Total Mesorectal Excision for Rectal Cancer
Urinary Retention Following Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Study Focus

Rectal Cancer

transanal total mesorectal excision

Interventional

procedure

Sponsor & Location

Yanhong Deng

Sun Yat-sen University

Timeline & Enrollment

N/A

Jan 30, 2016

Oct 30, 2023

526 participants

Primary Outcome

urinary retention

Summary

A comprehensive study with prospectively collected data. These patients were assigned to
 either the taTME group or the laTME group according to the surgery procedure received

ICD-10 Classifications

Malignant neoplasm of rectum
Carcinoma in situ: Rectum
Benign neoplasm: Rectum
Secondary malignant neoplasm of large intestine and rectum
Carcinoma in situ: Rectosigmoid junction

Data Source

ClinicalTrials.gov

NCT06147492

Non-Device Trial